title: Hypoglycemic adverse reactions to insulin and sulfonylureas.
abstract: Clearly, the insulins and oral sulfonylureas, while providing life-sustaining therapeutic effects, frequently cause serious, severe, and sometimes permanent and fatal adverse outcomes. A thorough understanding of their proper indications, requisite monitoring, patient education, and avoidance of interactive risks provide care givers with a clinical challenge each time these agents are used by their patients.
authors.affiliation: Rush Medical College, Chicago, Illinois.
authors.forename: J
authors.initials: J
authors.lastname: O'Donnell
mesh_terms: D003920:Diabetes Mellitus / Q000175:diagnosis / Q000188:drug therapy*; D004347:Drug Interactions; D005554:Forensic Medicine / Q000331:legislation & jurisprudence; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007328:Insulin / Q000009:adverse effects*; D013453:Sulfonylurea Compounds / Q000009:adverse effects*; D014481:United States
chemical_list: D007328:Insulin; D013453:Sulfonylurea Compounds